Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Phillips S.E.K., Celi A.C., Wehbe A., et al
For diarrhea Replace fluids and monitor how often diarrhea is occurring
doi: 10.1038/ncomms3192
[Published correction appears in Diabetes Care
Observing the following GLP-1s for weight loss Wegovy Saxenda Zepbound Oral Saxenda ETA to market if FDA approves NDA 2026-27 In development, Phase III trials CagriSema ETA to market if FDA approves NDA 2026-27 In development, Phase III trials How New GLP-1 Entrants and Generics Could Disrupt Pricing Strategies Other findings argue that, when generics (or in this case new GLP-1s) enter the market space, companies are forced to deploy new pricing strategies to remain competitive
Why dual agonists may overcome single-receptor tolerance The GIP receptor pathway is distinct from GLP-1 signaling
US$ 22.87
US$ 28.00
US$ 24.34
US$ 24.28
